MedTrace Logo

MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions

NCT02400632 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-03-17

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the efficacy of MagicTouch DCB in reducing late lumen loss / suppressing neointimal tissue formation as assessed by Quantitative Coronary Angiography / Intravascular Ultrasound examination for the treatment of coronary artery lesions ranging from 3.0 mm to 3.5 mm of diameter and lesion length ≤ 15 mm.

Conditions

Interventions

DEVICE

MAGIC-TOUCH Drug-eluting Balloon

in-stent restenosis treated with drug eluting balloon

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, PhD · Instituto Dante Pazzanese de Cardiologia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-07-30
Completion
2019-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02400632 on ClinicalTrials.gov